Variable | Comparison | All (n = 820) | CHB (n = 458) | CHC (n = 284) | |||
---|---|---|---|---|---|---|---|
HR (95% CI) | P-value | HR (95% CI) | P-value | HR (95% CI) | P-value | ||
Age (years) | >60 vs. ≦ 60 | ||||||
Sex | Male vs. Female | ||||||
AFP (ng/mL) | >200 vs. ≦ 200 | ||||||
Liver cirrhosis | Yes vs. No | 1.644 (1.180–2.290) | 0.003 | 1.828 (1.085–3.079) | 0.023 | ||
Diabetes | Yes vs. No | 2.064 (1.478–2.881) | < 0.001 | 2.633 (1.611–4.303) | < 0.001 | 1.940 (1.166–3.227) | 0.011 |
Child-Pugh grade | B vs. A | 1.915 (1.185–3.096) | 0.008 | 2.223 (1.051–4.702) | 0.037 | ||
Tumor number | Multiple vs. Single | ||||||
Tumor size (cm) | >2 vs. ≦ 2 | ||||||
Histology stages | Poor vs. well + moderate | ||||||
Vascular invasion | Yes vs. No | 2.339 (1.670–3.276) | < 0.001 | 2.283 (1.403–3.716) | 0.001 | 3.068 (1.808–5.206) | < 0.001 |
Statin | Yes vs. No | ||||||
NSAIDs | Yes vs. No | ||||||
Aspirin | Yes vs. No | ||||||
Metformin | Yes vs. No | ||||||
Antiviral therapy | Yes vs. No | 0.350 (0.241–0.509) | < 0.001 | ||||
NA therapy | Yes vs. No | 0.452 (0.277–0.740) | 0.002 | ||||
HCV therapy | Yes vs. No | 0.239 (0.129–0.445) | < 0.001 |